167 related articles for article (PubMed ID: 29334613)
1. Reduced miR-144-3p expression in serum and bone mediates osteoporosis pathogenesis by targeting RANK.
Wang C; He H; Wang L; Jiang Y; Xu Y
Biochem Cell Biol; 2018 Oct; 96(5):627-635. PubMed ID: 29334613
[TBL] [Abstract][Full Text] [Related]
2. miR-363-3p is activated by MYB and regulates osteoporosis pathogenesis via PTEN/PI3K/AKT signaling pathway.
Li M; Luo R; Yang W; Zhou Z; Li C
In Vitro Cell Dev Biol Anim; 2019 May; 55(5):376-386. PubMed ID: 31025251
[TBL] [Abstract][Full Text] [Related]
3. MiR-503 regulates osteoclastogenesis via targeting RANK.
Chen C; Cheng P; Xie H; Zhou HD; Wu XP; Liao EY; Luo XH
J Bone Miner Res; 2014 Feb; 29(2):338-47. PubMed ID: 23821519
[TBL] [Abstract][Full Text] [Related]
4. MiRNA-483-5p is involved in the pathogenesis of osteoporosis by promoting osteoclast differentiation.
Li K; Chen S; Cai P; Chen K; Li L; Yang X; Yi J; Luo X; Du Y; Zheng H
Mol Cell Probes; 2020 Feb; 49():101479. PubMed ID: 31706013
[TBL] [Abstract][Full Text] [Related]
5. A potential therapeutic target for regulating osteoporosis via suppression of osteoclast differentiation.
Sun Q; Zhang B; Zhu W; Wei W; Ma J; Tay FR
J Dent; 2019 Mar; 82():91-97. PubMed ID: 30716449
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-338-3p inhibits glucocorticoid-induced osteoclast formation through RANKL targeting.
Zhang XH; Geng GL; Su B; Liang CP; Wang F; Bao JC
Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706599
[TBL] [Abstract][Full Text] [Related]
7. Role of miR-222-3p in c-Src-Mediated Regulation of Osteoclastogenesis.
Takigawa S; Chen A; Wan Q; Na S; Sudo A; Yokota H; Hamamura K
Int J Mol Sci; 2016 Feb; 17(2):240. PubMed ID: 26891296
[TBL] [Abstract][Full Text] [Related]
8. Osteoclastogenic capacity of peripheral blood mononuclear cells is not different between women with and without osteoporosis.
Koek WNH; van der Eerden BCJ; Alves RDAM; van Driel M; Schreuders-Koedam M; Zillikens MC; van Leeuwen JPTM
Bone; 2017 Feb; 95():108-114. PubMed ID: 27845263
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-25-3p regulates osteoclasts through nuclear factor I X.
Huang Y; Ren K; Yao T; Zhu H; Xu Y; Ye H; Chen Z; Lv J; Shen S; Ma J
Biochem Biophys Res Commun; 2020 Jan; 522(1):74-80. PubMed ID: 31740002
[TBL] [Abstract][Full Text] [Related]
10. Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation.
Li D; Liu J; Guo B; Liang C; Dang L; Lu C; He X; Cheung HY; Xu L; Lu C; He B; Liu B; Shaikh AB; Li F; Wang L; Yang Z; Au DW; Peng S; Zhang Z; Zhang BT; Pan X; Qian A; Shang P; Xiao L; Jiang B; Wong CK; Xu J; Bian Z; Liang Z; Guo DA; Zhu H; Tan W; Lu A; Zhang G
Nat Commun; 2016 Mar; 7():10872. PubMed ID: 26947250
[TBL] [Abstract][Full Text] [Related]
11. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-548-3p overexpression inhibits proliferation, migration and invasion in osteoblast-like cells by targeting STAT1 and MAFB.
Ramírez-Salazar EG; Almeraya EV; López-Perez TV; Patiño N; Salmeron J; Velázquez-Cruz R
J Biochem; 2020 Sep; 168(3):203-211. PubMed ID: 32196088
[TBL] [Abstract][Full Text] [Related]
13. miR-218 is involved in the negative regulation of osteoclastogenesis and bone resorption by partial suppression of p38MAPK-c-Fos-NFATc1 signaling: Potential role for osteopenic diseases.
Qu B; Xia X; Yan M; Gong K; Deng S; Huang G; Ma Z; Pan X
Exp Cell Res; 2015 Oct; 338(1):89-96. PubMed ID: 26216483
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of miRNA-22-3p attenuates osteoporosis by targeting MAPK14.
Jia X; Yang M; Hu W; Cai S
Exp Ther Med; 2021 Jul; 22(1):692. PubMed ID: 33986857
[TBL] [Abstract][Full Text] [Related]
15. miR-145-5p Increases Osteoclast Numbers In Vitro and Aggravates Bone Erosion in Collagen-Induced Arthritis by Targeting Osteoprotegerin.
Chen Y; Wang X; Yang M; Ruan W; Wei W; Gu D; Wang J; Guo X; Guo L; Yuan Y
Med Sci Monit; 2018 Jul; 24():5292-5300. PubMed ID: 30059491
[TBL] [Abstract][Full Text] [Related]
16. miR-214 promotes osteoclastogenesis by targeting Pten/PI3k/Akt pathway.
Zhao C; Sun W; Zhang P; Ling S; Li Y; Zhao D; Peng J; Wang A; Li Q; Song J; Wang C; Xu X; Xu Z; Zhong G; Han B; Chang YZ; Li Y
RNA Biol; 2015; 12(3):343-53. PubMed ID: 25826666
[TBL] [Abstract][Full Text] [Related]
17. Circulating microRNA Signatures in Patients With Idiopathic and Postmenopausal Osteoporosis and Fragility Fractures.
Kocijan R; Muschitz C; Geiger E; Skalicky S; Baierl A; Dormann R; Plachel F; Feichtinger X; Heimel P; Fahrleitner-Pammer A; Grillari J; Redl H; Resch H; Hackl M
J Clin Endocrinol Metab; 2016 Nov; 101(11):4125-4134. PubMed ID: 27552543
[TBL] [Abstract][Full Text] [Related]
18. Bone and muscle specific circulating microRNAs in postmenopausal women based on osteoporosis and sarcopenia status.
Chen Z; Bemben MG; Bemben DA
Bone; 2019 Mar; 120():271-278. PubMed ID: 30408612
[TBL] [Abstract][Full Text] [Related]
19. Bone-related Circulating MicroRNAs miR-29b-3p, miR-550a-3p, and miR-324-3p and their Association to Bone Microstructure and Histomorphometry.
Feichtinger X; Muschitz C; Heimel P; Baierl A; Fahrleitner-Pammer A; Redl H; Resch H; Geiger E; Skalicky S; Dormann R; Plachel F; Pietschmann P; Grillari J; Hackl M; Kocijan R
Sci Rep; 2018 Mar; 8(1):4867. PubMed ID: 29559644
[TBL] [Abstract][Full Text] [Related]
20. AAV-mediated delivery of osteoblast/osteoclast-regulating miRNAs for osteoporosis therapy.
John AA; Xie J; Yang YS; Kim JM; Lin C; Ma H; Gao G; Shim JH
Mol Ther Nucleic Acids; 2022 Sep; 29():296-311. PubMed ID: 35950212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
